The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

NCT06883656 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)
Renal Insuficiency

Interventions

DRUG: SAL067

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.